SHC vs MMM

For growth investors, Sotera Health Company (SHC) is the stronger pick with 5.

7% revenue growth year-over-year, versus 1. 5% for 3M Company (MMM). 3M Company (MMM) offers the better valuation at 24. 4x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate Sotera Health Company (SHC) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, 3M Company (MMM) is the cheapest at 24.

4x versus Sotera Health Company at 58. 5x. On forward P/E, Sotera Health Company is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, 3M Company (MMM) delivered a total return of -1.

1%, compared to -32. 9% for Sotera Health Company (SHC). Over 10 years, the gap is even starker: MMM returned +34. 2% versus SHC's -37. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), 3M Company (MMM) is the lower-risk stock at 1.

06β versus Sotera Health Company's 1. 32β — meaning SHC is approximately 25% more volatile than MMM relative to the S&P 500. On balance sheet safety, 3M Company (MMM) carries a lower debt/equity ratio of 3% versus 4% for Sotera Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sotera Health Company (SHC) is pulling ahead at 5.

7% versus 1. 5% for 3M Company (MMM). On earnings-per-share growth, the picture is similar: Sotera Health Company grew EPS 68. 8% year-over-year, compared to -20. 5% for 3M Company. Over a 3-year CAGR, SHC leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

3M Company (MMM) is the more profitable company, earning 13.

0% net margin versus 6. 7% for Sotera Health Company — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SHC leads at 33. 8% versus 18. 3% for MMM. At the gross margin level — before operating expenses — SHC leads at 55. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Sotera Health Company (SHC) trades at 16.

4x forward P/E versus 16. 9x for 3M Company — 0. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SHC: 39. 2% to $22. 00.

In this comparison, MMM (1.

5% yield) pays a dividend. SHC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, 3M Company (MMM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

06), 1. 5% yield). Both have compounded well over 10 years (MMM: +34. 2%, SHC: -37. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SHC (Healthcare) and MMM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

MMM pays a dividend while SHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.